The license covers ICRISAT's full range of mandate crops, including pulses, millets and oilseeds such as sorghum, pearl millet, chickpea, pigeonpea and groundnut. Unlike classical breeding, which can take many years to combine desirable traits, gene editing allows researchers to accelerate the development of varieties with improved tolerance to drought, heat, pests and diseases, along with better productivity and nutritional quality, all without introducing DNA from unrelated species.
ICRISAT Director General Dr Himanshu Pathak called the agreement a transformative milestone, noting that the new capability will accelerate the delivery of practical crop innovations that strengthen food security. Dr Wendy Srnic, Vice President of Biotechnology at Corteva, said the company is proud to help smallholder farmers across Asia and Africa access gene editing technology. Link to the original post.
The agreement is a good example of a broader global pattern. More research institutions and breeding programs are securing long-term rights to New Genomic Techniques (NGTs) for public-good, humanitarian purposes, not only for commercial crop development. As access agreements like this one become more common, understanding the regulatory environment around NGTs becomes just as important as the science itself. For an up-to-date, global overview of how NGT regulation is evolving, visit our sister resource, editagenome.org.
Healthy Crops will continue to follow developments in gene editing licensing and deployment models, as they shape how quickly disease-resistant, climate-resilient crop varieties can reach the farmers who need them most.